AMANDA CALDWELL: Open Payments
NPI 1760063978 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 38 payments from 15 companies in 2025. Trend: 2023 $36 · 2024 $362 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $232 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $91 |
| Dexcom, Inc. | 2 | $76 |
| PFIZER INC. | 2 | $37 |
| Novo Nordisk Inc | 2 | $34 |
| Seqirus USA Inc | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $23 |
| Lundbeck LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
Products named: VRAYLAR, XIFAXAN, Dexcom G6 Transmitter, QULIPTA, PREVNAR 20, Fluad, DUPIXENT, The Cologuard Plus Collection Kit.
Industry payments across VA — which companies pay providers there.
